arrow
J

Justis P. Ehlers

cleveland clinic
H指数:54
被引数:9,934

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Danicopan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results From the Phase 2 Randomized OnwarD Trial

达尼考潘治疗与年龄相关性黄斑变性相关的地图样萎缩:来自OnwarD二期随机试验的结果

2026-08-170
OAAI
Outcomes and Complications of Pars Plana Vitrectomy for Non-clearing Vitreous Hemorrhage without Tractional Elements

玻璃体切除术治疗无牵引元件的非清除玻璃体出血的结果和并发症

2026-01-290
PREAI
Real-World Functional and Anatomic Outcomes With Aflibercept 8.0 mg in Patients With Diabetic Macular Edema

Barbosa, G.C.S.; Bala, S.; Mohan, N.; Srivastava, S.K.; Kaiser, P.K.; Sastry, A.; Babiuch, A.S.; Sears, J.; Talcott, K.E.; Yuan, A.; 等. 糖尿病黄斑水肿患者使用Aflibercept 8.0 mg的实世界功能和解剖学结局。J. Vitreoretin. Dis. 2025, 10, 74–82. [Google Scholar] [CrossRef]

2026-01-011
PRE
Designing the next generation of clinical trials in intermediate AMD-a consensus driven, pragmatic, proof of concept early intervention study

在中级AMD中设计下一代临床试验-共识驱动,务实,概念验证早期干预研究

2025-06-010
PRE
ReCLAIM-2: A Randomized Phase II Clinical Trial Evaluating Elamipretide in Age-related Macular Degeneration, Geographic Atrophy Growth, Visual Function, and Ellipsoid Zone Preservation

Recland-2: 一项随机II期临床试验,评估了Elamipretide在与年龄相关的黄斑变性,地理萎缩的生长,视觉功能和椭圆体区域的保存

2025-01-013
OAAI
Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in Diabetic Retinopathy in Protocol AA

评估Protocol AA中糖尿病视网膜病变的基线超广域荧光血管造影定量渗漏参数与超广域眼底特征及临床参数的关系

2024-08-010
PRE